2022
DOI: 10.1016/j.jbiosc.2021.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Gel-in-water nanodispersion for potential application in intravenous delivery of anticancer drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 34 publications
0
4
0
Order By: Relevance
“…Intravenous administration of paclitaxel-loaded NGDs shows an anti-cancer effect against lung cancer in vivo with a significant reduction in tumor volume (p < 0.05). Paclitaxelloaded NGDs may be a promising carrier for sustained drug release and chemotherapy agents (Fardous et al, 2022). Sagiri et al (2015) used the ionotropic gelation method to synthesize organogel-entrapped core-shell (organogel-alginate) type new microparticles.…”
Section: Organogels: Novel Biomaterials In Medication and Pharmaceuti...mentioning
confidence: 99%
“…Intravenous administration of paclitaxel-loaded NGDs shows an anti-cancer effect against lung cancer in vivo with a significant reduction in tumor volume (p < 0.05). Paclitaxelloaded NGDs may be a promising carrier for sustained drug release and chemotherapy agents (Fardous et al, 2022). Sagiri et al (2015) used the ionotropic gelation method to synthesize organogel-entrapped core-shell (organogel-alginate) type new microparticles.…”
Section: Organogels: Novel Biomaterials In Medication and Pharmaceuti...mentioning
confidence: 99%
“…20,21 Bulk organogels from LMWGs can be easily downsized to aqueous colloidal dispersions of gelled-oil nanoparticles (GNPs) via a two-step process in which emulsified oil droplets are typically generated via a hot emulsification process followed by cooling. 24−27 Although GNPs have exhibited the potential for the encapsulation, protection, and delivery of a variety of bioactives with low water solubility (i.e., nile red and efavirenz, 28 rose bengal and hypericine, 29 rhodamine 123, 30 curcumin, 31,32 curcuminaldehyde, 33 sunscreen, 34 indomethacin and ketoconazole, 35 metallophthalocyanine, 36 flurbiprofen, 37 β-carotene, 38 coumarin, 39 paclitaxel, 40,41 and doxorubicin 42 ), they are still relatively seldom used. The commercially available 12-hydroxystearic acid (HSA) is the most commonly used LMWG for GNPs, 25,28,[34][35][36][37]40,41 and thus the development of new custom LWMGs offers the opportunity to form gels with a wider variety of organic liquids 43,44 as well as introduce other interesting properties to trigger different types of stimuliresponsive systems that could enable tunable release characteristics.…”
Section: ■ Introductionmentioning
confidence: 99%
“…24−27 Although GNPs have exhibited the potential for the encapsulation, protection, and delivery of a variety of bioactives with low water solubility (i.e., nile red and efavirenz, 28 rose bengal and hypericine, 29 rhodamine 123, 30 curcumin, 31,32 curcuminaldehyde, 33 sunscreen, 34 indomethacin and ketoconazole, 35 metallophthalocyanine, 36 flurbiprofen, 37 β-carotene, 38 coumarin, 39 paclitaxel, 40,41 and doxorubicin 42 ), they are still relatively seldom used. The commercially available 12-hydroxystearic acid (HSA) is the most commonly used LMWG for GNPs, 25,28,[34][35][36][37]40,41 and thus the development of new custom LWMGs offers the opportunity to form gels with a wider variety of organic liquids 43,44 as well as introduce other interesting properties to trigger different types of stimuliresponsive systems that could enable tunable release characteristics. 45−47 Recently, we reported a family of versatile and efficient LMWGs based on N-alkylated primary oxalamides (i.e., AOx24, Figure S1) for a variety of different organic solvents, which were also biocompatible with mouse mast cells.…”
Section: ■ Introductionmentioning
confidence: 99%
See 1 more Smart Citation